Decoy Therapeutics is trading 5.65% down at $1.17, likely amid broader market pressure after hotter-than-expected inflation. - No confirmed company-specific catalyst surfaced for the October 14 decline. - September CPI was 3.7% year over year versus 3.6% expected; Reuters reported rising Treasury yields and weaker stock futures as rate-hike bets increased. - The September warrant-release item was described as a correction to a prior announcement, not a new transaction.